Cargando…
A comparison study of outcome measures for epidermolysis bullosa: Epidermolysis Bullosa Disease Activity and Scarring Index (EBDASI) and the Instrument for Scoring Clinical Outcomes of Research for Epidermolysis Bullosa (iscorEB)
BACKGROUND: The success of clinical trials in Epidermolysis Bullosa (EB) is dependent upon the availability of a valid and reliable scoring tool that can accurately assess and monitor disease severity. The Epidermolysis Bullosa Disease Activity and Scarring Index (EBDASI) and Instrument for Scoring...
Autores principales: | Rogers, Clare L., Gibson, Matthew, Kern, Johannes S., Martin, Linda K., Robertson, Susan J., Daniel, Benjamin S., Su, John C., Murrell, Oliver G.C., Feng, Grant, Murrell, Dedee F. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8362226/ https://www.ncbi.nlm.nih.gov/pubmed/34409361 http://dx.doi.org/10.1016/j.jdin.2020.12.007 |
Ejemplares similares
-
The Epidermolysis Bullosa Disease Activity and Scarring Index (EBDASI): grading disease severity and assessing responsiveness to clinical change in epidermolysis bullosa
por: Jain, S.V., et al.
Publicado: (2016) -
Long-term follow-up of epidermolysis bullosa in real practice shows stability of the Epidermolysis Bullosa Disease Activity and Scarring Index and improvement with some off-label therapies
por: Ho, Genevieve, et al.
Publicado: (2022) -
Managing epidermolysis bullosa during the coronavirus pandemic: Experience and ideals
por: Ramirez-Quizon, Mae, et al.
Publicado: (2021) -
Prevalence of anemia in patients with epidermolysis bullosa registered in Australia
por: Hwang, Shelley Ji Eun, et al.
Publicado: (2015) -
Inherited epidermolysis bullosa
por: Fine, Jo-David
Publicado: (2010)